Clinical trials of CAR-T cells in China

Article English OPEN
Liu, Bingshan; Song, Yongping; Liu, Delong;
(2017)

Abstract Novel immunotherapeutic agents targeting tumor-site microenvironment are revolutionizing cancer therapy. Chimeric antigen receptor (CAR)-engineered T cells are widely studied for cancer immunotherapy. CD19-specific CAR-T cells, tisagenlecleucel, have been recen... View more
Share - Bookmark